Konverge Plus (Olmesartan Medoxomil, Amlodipine, Hydrochlorothiazide)

Olmesartan blocks angiotensin II receptors, reducing vasoconstriction and aldosterone release. Amlodipine relaxes vascular smooth muscle by inhibiting calcium entry, causing arterial dilation. Hydrochlorothiazide increases urinary sodium excretion, decreasing plasma volume. Together they provide a synergistic reduction in blood pressure.

The appropriate dose of Konverge Plus is determined by the prescribing clinician based on the patient’s blood pressure, renal function, and overall treatment plan. Dosage adjustments are made according to clinical response and tolerability.

Konverge Plus is contraindicated in pregnancy because the components may harm the developing fetus. Safety during breastfeeding has not been established, and the medication should be avoided unless the benefits clearly outweigh the risks.

To place an order, submit an enquiry on the Konverge Plus product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any required import documentation.

Compared with single‑agent therapies, Konverge Plus offers the convenience of three proven antihypertensive mechanisms in one tablet, potentially improving adherence. It is an alternative to separate prescriptions of an ARB, a calcium‑channel blocker, and a thiazide diuretic, providing similar efficacy with reduced pill burden.

Konverge Plus should be stored at room temperature, below 25 °C, in the original packaging. Keep the tablet container tightly closed, protect it from moisture and direct light, and store out of reach of children.

Konverge Plus is taken orally, usually once daily, with or without food, as directed by the prescribing physician. Swallow the tablet whole with a full glass of water; do not crush or chew it.

Serious adverse events, although rare, include severe hypotension, acute kidney injury, hyperkalemia, angioedema, pancreatitis, and significant liver dysfunction. Patients should seek immediate medical attention if they experience symptoms such as sudden dizziness, swelling of the face or throat, severe abdominal pain, or jaundice.

Konverge Plus should not be used by individuals with known hypersensitivity to any of its components, pregnant women, patients with severe hepatic impairment, or those with uncontrolled electrolyte disturbances. Clinicians should also avoid prescribing it to patients with severe renal insufficiency without careful monitoring.